Академический Документы
Профессиональный Документы
Культура Документы
Original Article
Abstract
Objective: To study the association of panic disorder with severity of anxiety symptoms and quality of
life among individuals presenting with headache.
Methods: This was a single-centre, cross-sectional, observational, questionnaire-based study performed
at the psychiatry outpatient department of a tertiary care hospital. Participants of both genders, aged
between 18 and 60 years, and having headache as a presenting complaint for at least 3 months were
evaluated for symptoms of panic disorder. The severity of headache was evaluated with the visual
analogue scale and that of anxiety disorder with the Hamilton Anxiety Rating Scale (HAM-A). The
quality of life was evaluated with the World Health Organization Quality of Life Scale brief version.
Proportions of participants were compared using Chi-square test, and scores by Mann-Whitney test or
Kruskal-Wallis test followed by Dunns post-hoc multiple comparisons.
Results: The frequency of panic disorder among patients with headache was 67%. Those with daily
headache and panic disorder (with or without agoraphobia) showed higher HAM-A score and poorer
quality of life than those with intermittent headache and without panic disorder, respectively.
Conclusions: Co-morbid panic disorder among patients with headache was associated with high anxiety
score and poor quality of life.
Key words: Anxiety; Headache; Panic disorder; Quality of life
18603
HAM-A
Mann-WhitneyKruskal-Wallis
HAM-A
10
Introduction
Headache is a common cause for medical consultation.1
Tension-type headache (TTH) is the most common cause for
primary headache (69%), followed by migraine headache
(16%).2 Headache often results in considerable disability
and poor quality of life.2 The present lifetime disability
attributable to migraine of 0.5 in terms of disabilityadjusted life years is equal to or more than that of several
other major chronic illnesses such as hypertension, breast
cancer, and rheumatoid arthritis.1 Psychiatric illnesses are
commonly associated with headache. The relationship of
anxiety disorders and depression with migraine has been
established in various studies.3-5 Anxiety is the commonest
2014 Hong Kong College of Psychiatrists
Methods
Results
Discussion
Psychiatric disorders such as anxiety disorders and
depression are more common among patients with recurrent
headache than in the general population.3,13 A majority of
11
Table 1. Demographic variables according to severity of anxiety symptoms based on Hamilton Anxiety Rating Scale
scores.*
Characteristics
Age (years)
Gender
Male (n = 24)
Female (n = 76)
Residence
Rural / town (n = 53)
Urban (n = 47)
Religion
Hindu (n = 79)
Muslim (n = 21)
Marital status
Married (n = 94)
Unmarried (n = 6)
Education
Illiterate (n = 37)
Primary (n = 43)
Post-primary (n = 20)
Socio-economic status
1-2 (n = 62)
3 (n = 38)
Tobacco use
Yes (n = 31)
No (n = 69)
Headache characteristic
Dull aching (n = 31)
Throbbing (n = 51)
Mixed (n = 18)
Visual analogue scale
Duration of headache (months)
Panic disorder
With agoraphobia (n = 23)
Without agoraphobia (n = 44)
No panic disorder (n = 33)
History of headache or any other psychiatric illnesses
Yes (n = 25)
No (n = 75)
Family history of headache or any other psychiatric illnesses
Yes (n = 23)
No (n = 77)
Mild
(n = 33)
Mild to
moderate
(n = 24)
Moderate to p Value
severe
(n = 43)
34 (20-58)
32 (21-40)
35 (19-54)
11
22
6
18
7
36
20
13
10
14
23
20
29
4
19
5
31
12
30
3
23
1
41
2
10
14
9
11
9
4
16
20
7
19
14
14
10
29
14
13
20
4
20
14
29
8
22
3
5 (3-9)
12 (3-120)
8
13
3
7 (3-9)
30 (4-240)
15
16
12
7 (1-10)
18 (3-240)
2
4
27
2
18
4
19
22
2
6
27
6
18
13
30
4
29
7
17
12
31
0.55
0.22
0.36
0.24
0.65
0.64
0.62
0.17
0.08
0.63
0.08
< 0.0001
0.48
0.19
12
Table 2. Association of panic disorder with the severity of headache, anxiety, and quality of life.*
Item
7 (1-10)
28 (13-41)
50
45.83
66.66
50
Panic disorder
without
agoraphobia
(n = 44)
6.5 (3-10)
24.4 (9-41)
(28.5-78.5)
(29.1-66.6)
(16.6-83.3)
(21.9-65.6)
50
50
66.66
53.13
(39.2-85.7)
(33.3-83.3)
(33.3-83.3)
(21.8-68.7)
No panic disorder
(n = 33)
6 (3-9)
14 (2-29)
60.71 (35.7-75.0)
62.5 (41.6-83.3)
66.66 (33.3-100)
62.5 (12.5-100)
p Value
0.98
< 0.0001
0.002
< 0.0001
0.09
0.0003
Abbreviations: VAS = visual analogue scale; HAM-A = Hamilton Anxiety Rating Scale; and WHOQOL-BREF = World Health
Organization Quality of Life Scale brief version.
*
Data are shown in median (interquartile range). All the groups were compared by Kruskal-Wallis test followed by Dunns post-hoc
multiple comparisons.
Table 3. Association of frequency of headache with severity of headache, anxiety, and quality of life.*
Item
Intermittent (n = 43)
5 (1-10)
19 (2-40)
57.14
54.16
66.66
56.25
(39.3-75)
(33.3-83.3)
(16.7-100)
(21.9-100)
Daily (n = 57)
p Value
53.57 (28.6-85.7)
50 (29.2-75)
66.66 (25-91.7)
50 (12.5-84.4)
0.07
0.04
0.13
0.14
7 (3-10)
25 (6-41)
0.06
0.04
Abbreviations: VAS = visual analogue scale; HAM-A = Hamilton Anxiety Rating Scale; and WHOQOL-BREF = World Health
Organization Quality of Life Scale brief version.
*
Data are shown in median (interquartile range). All the groups were compared by Mann Whitney U test.
Table 4. Association of severity of anxiety (based on Hamilton Anxiety Rating Scale) with quality of life.*
Item
WHOQOL-BREF
Physical health
Psychological health
Social relationship
Environment
Mild (n = 33)
60.71 (46.4-75)
62.5 (41.7-83.3)
66.67 (33.3-100)
62.5 (31.3-100)
Mild to moderate
(n = 24)
Moderate to severe
(n = 43)
p Value
53.57
54.16
66.67
56.25
46.43
45.83
58.33
46.88
0.002
< 0.0001
0.09
0.0003
(42.9-85.7)
(33.3-70.8)
(50-83.3)
(28.1-71.9)
(28.6-64.3)
(29.2-83.3)
(16.67-83.3)
(12.5-65.6)
Abbreviation: WHOQOL-BREF = World Health Organization Quality of Life Scale brief version.
*
Data are shown in median (interquartile range). All the groups were compared by Kruskal-Wallis test followed by Dunns post-hoc
multiple comparisons.
13
Limitations
Although this is the first study to examine the association
of panic disorder with severity of anxiety symptoms and
quality of life among participants with headache, it has
several limitations such as recruiting subjects from a single
centre, an open-label study, and a small sample size. As
participants were recruited from the psychiatry outpatient
department of a tertiary care hospital, they did not represent
the general population. Being a cross-sectional study,
cause-effect relationship for headache and anxiety disorders
cannot be established. As such, prospective cohort studies
to examine such association are recommended.
Conclusions
This study showed that there was high frequency of panic
disorder among patients with headache. Patients with severe
anxiety symptoms had poorer quality of life. Patients with
daily headache showed more severe anxiety symptoms and
poorer quality of life than those with intermittent headache.
East Asian Arch Psychiatry 2014, Vol 24, No.1
Declaration
The authors declared no source of financial support and
conflict of interest in this study.
Acknowledgements
We would like to thank Prof Mukesh Samani, Head of
Department of Psychiatry, P. D. U. Medical College, Rajkot,
Gujarat, India for guidance about applying World Health
Organisation Quality of Life (WHOQOL-BREF) scale,
as well as Dr Divyesh R. Mandavia, Tutor, Department of
Pharmacology, Government Medical College, Bhavnagar,
Gujarat, India for guidance in statistical analysis, manuscript
preparation, editing, and review.
References
1. Merikangas KR, Merikangas JR. Neuropsychiatric aspects of
headache. In: Kaplan HI, Sadock BJ, editors. Kaplan and Sadocks
comprehensive textbook of psychiatry. 9th ed. Philadelphia: Lippincott
Williams & Wilkins; 2009: 559-66.
2. Goadsby PJ, Raskin NH. Headache. In: Fauci AS, Braunwald E,
Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrisons
principles of internal medicine. 17th ed. New York: McGraw-Hill
Medical; 2008: 95-107.
3. Merikangas KR, Angst J, Isler H. Migraine and psychopathology.
Results of the Zurich cohort study of young adults. Arch Gen
Psychiatry 1990;47:849-53.
4. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders and
suicide attempts: an epidemiologic study of young adults. Psychiatry
Res 1991;37:11-23.
5. McWilliams LA, Goodwin RD, Cox BJ. Depression and anxiety
associated with three pain conditions: results from a nationally
representative sample. Pain 2004;111:77-83.
6. Peres MF, Zukerman E, Young WB, Silberstein SD. Fatigue in chronic
migraine patients. Cephalalgia 2002;22:720-4.
7. Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review.
Cephalalgia 2005;25:165-78.
8. Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH, Reading
AE. Pain measurement: an overview. Pain 1985;22:1-31.
9. American Psychiatric Association. Diagnostic and statistical manual
of mental disorders, 4th ed. Washington DC; American Psychiatric
Association; 1994.
10. Hamilton M. The assessment of anxiety states by rating. Br J Med
Psychol 1959;32:50-5.
11. WHOQOL Group. Development of the World Health Organization
WHOQOL-BREF quality of life assessment. Psychol Med
1998;28:551-8.
12. Kumar N, Gupta N, Kishore J. Kuppuswamys socioeconomic scale:
updating income ranges for the year 2012. Indian J Public Health
2012;56:103-4.
13. Breslau N, Davis GC. Migraine, physical health and psychiatric
disorder: a prospective epidemiologic study in young adults. J
Psychiatr Res 1993;27:211-21.
14. Lake AE 3rd, Rains JC, Penzien DB, Lipchik GL. Headache and
psychiatric comorbidity: historical context, clinical implications, and
research relevance. Headache 2005;45:493-506.
15. Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A,
et al. The global burden of headache: a documentation of headache
prevalence and disability worldwide. Cephalalgia 2007;27:193-210.
16. Mercante JP, Peres MF, Bernik MA. Primary headaches in patients
with generalized anxiety disorder. J Headache Pain 2011;12:331-8.
17. Mongini F, Rota E, Deregibus A, Ferrero L, Migliaretti G, Cavallo F, et
al. Accompanying symptoms and psychiatric comorbidity in migraine
and tension-type headache patients. J Psychosom Res 2006;61:447-51.
18. Wang SJ, Fuh JL, Lu SR, Juang KD. Quality of life differs among
headache diagnoses: analysis of SF 36 survey in 901 headache patients.
Pain 2001;89:285-92.
19. Wiendels NJ, van Haestregt A, Knuistingh Neven A, Spinhoven P,
Zitman FG, Assendelft WJ, et al. Chronic frequent headache in the
general population: comorbidity and quality of life. Cephalalgia
2006;26:1443-50.
20. Autret A, Roux S, Rimbaux-Lepage S, Valade D, Debiais S; West
Migraine Study Group. Psychopathology and quality of life burden in
chronic daily headache: influence of migraine symptoms. J Headache
Pain 2010;11:247-53.
21. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB.
Sociodemographic and comorbidity profiles of chronic migraine
and episodic migraine sufferers. J Neurol Neurosurg Psychiatry
2010;81:428-32.
22. Zwart JA, Dyb G, Hagen K, degrd KJ, Dahl AA, Bovim G, et al.
Depression and anxiety disorders associated with headache frequency.
The Nord-Trndelag Health Study. Eur J Neurol 2003;10:147-52.
23. Smitherman TA, Penzien DB, Maizels M. Anxiety disorders and
migraine intractability and progression. Curr Pain Headache Rep
2008;12:224-9.
24. Smitherman TA, Maizels M, Penzien DB. Headache chronification:
screening and behavioral management of comorbid depressive and
anxiety disorders. Headache 2008;48:45-50.
25. Verri AP, Proietti Cecchini A, Galli C, Granella F, Sandrini G, Nappi
G. Psychiatric comorbidity in chronic daily headache. Cephalalgia
1998;18 Suppl 21:45-9.
26. Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP. Comorbidity of depressive
and anxiety disorders in chronic daily headache and its subtypes.
Headache 2000;40:818-23.
27. Sharma H, Shah S. Psychiatric comorbidity of headache in a medical
relief camp in a rural area. Indian J Psychiatry. 2006;48:185-8.
28. Breslau N, Rasmussen BK. The impact of migraine: epidemiology, risk
factors, and co-morbidities. Neurology 2001;56 (6 Suppl 1):S4-12.
29. Lantri-Minet M, Radat F, Chautard MH, Lucas C. Anxiety and
depression associated with migraine: influence on migraine subjects
disability and quality of life, and acute migraine management. Pain
2005;118:319-26.
15